Gamma-Aminobutyric Acid (GABA) in the CSF of Schizophrenic Patients Before and After Neuroleptic Treatment
- 1 February 1978
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 132 (2) , 145-148
- https://doi.org/10.1192/bjp.132.2.145
Abstract
Gamma-aminobutyric acid (GABA) levels in the CSF were measured in 9 normal individuals, 17 drug-free schizophrenic patients and 10 of these same schizophrenic patients after neuroleptic treatment. There was no significant difference between CSF level of GABA in the control group compared to those in schizophrenic patients; however, 6 of the 7 lowest GABA levels were from schizophrenic patients. There was a significant decline of 12 per cent in mean GABA levels in the CSF after a mean of two months of neuroleptic treatment.Keywords
This publication has 13 references indexed in Scilit:
- Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatmentPsychopharmacology, 1976
- Cerebrospinal Fluid Amine Metabolites in Acute SchizophreniaArchives of General Psychiatry, 1975
- Gamma-Aminobutyric Acid in CSF in SchizophreniaNew England Journal of Medicine, 1975
- Effects of acute haloperidol on the gamma-aminobutyric acid system in rat striatum and substantia nigraBrain Research, 1975
- Measurement of GABA in human cerebrospinal fluidBiochemical Medicine, 1975
- Central Dopamine Turnover in Schizophrenic SyndromesArchives of General Psychiatry, 1974
- Drugs, Neurotransmitters, and SchizophreniaScience, 1974
- GABA blockade, dopamine and schizophrenia: Experimental studies in the catPsychopharmacology, 1974
- Effect of aminooxyacetic acid, thiosemicarbazide and haloperidol on the metabolism and half-lives of glutamate and GABA in rat brainBiochemical Pharmacology, 1973
- Central Synaptic Transmission-Microelectrophoretic StudiesAnnual Review of Pharmacology, 1969